SCHEMBL3435133

SCHEMBL3435133

CC(=O)NC1CCc2nc(N)sc2C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN4A P35499 6/20 0.61
SCN3A Q9NY46 5/20 0.61
SCN9A Q15858 5/20 0.60
DRD3 P35462 4/20 0.59
DRD2 P14416 3/20 0.59
HRH2 P25021 2/20 0.59
ADRA2A P08913 2/20 0.59
DRD4 P21917 2/20 0.59
ADRB2 P07550 1/20 0.59
HTR1A P08908 1/20 0.59
ADRA2B P18089 1/20 0.59
ADRA2C P18825 1/20 0.59
HTR1B P28222 1/20 0.59
HTR2A P28223 1/20 0.59
HTR7 P34969 1/20 0.59
ADRA1A P35348 1/20 0.59
HRH1 P35367 1/20 0.59
HTR2B P41595 1/20 0.59
SIGMAR1 Q99720 1/20 0.59
HRH4 Q9H3N8 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5810193 1.00 SCN4A (0.61) SCN4ASCN3ASCN9ADRD3DRD2
SCHEMBL5810188 1.00 SCN4A (0.61) SCN4ASCN3ASCN9ADRD3DRD2
Bromide SCHEMBL4631988 0.99 SCN4A (0.60) SCN4ASCN3ASCN9ADRD3DRD2
Bromide SCHEMBL1234856 0.99 SCN4A (0.60) SCN4ASCN3ASCN9ADRD3DRD2
SCHEMBL3025573 0.87 SCN4A (0.62) SCN4ASCN3ASCN9ADRD3DRD2
SCHEMBL8204692 0.85 DRD3 (0.62) SCN4ASCN3ASCN9ADRD3DRD2
SCHEMBL1031126 0.85 DRD3 (0.62) SCN4ASCN3ASCN9ADRD3DRD2
SCHEMBL1031127 0.85 DRD3 (0.62) SCN4ASCN3ASCN9ADRD3DRD2
SCHEMBL31214169 0.84 SCN4A (0.67) SCN4ASCN3ASCN9ADRD3DRD2
Bromide SCHEMBL4103965 0.84 DRD3 (0.61) SCN4ASCN3ASCN9ADRD3DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111018805-A Synthesis and separation method of pramipexole intermediate 江苏汉斯通药业有限公司 2020-04-17 CN claimed
CN-110734413-A Preparation method of pramipexole intermediates 2, 6-diamino-4, 5,6, 7-tetrahydrobenzothiazole 山东铂源药业有限公司 2020-01-31 CN claimed
WO-2008104847-A2 PROCESSES FOR THE PREPARATION OF PRAMIPEXOLE AND SALTS THEREOF WOCKHARDT RESEARCH CENTRE (IN) 2008-09-04 WO claimed
EP-1562921-B1 PROCESS FOR PREPARING 2,6-DIAMINO-4,5,6,7-TETRAHYDRO-BENZOTHIAZOLE CIPLA LTD (IN) 2008-05-21 EP claimed
US-7285669-B2 Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole CIPLA LIMITED (IN) 2007-10-23 US claimed
US-20060100256-A1 Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole CIPLA LIMITED (IN) 2006-05-11 US claimed
EP-1562921-A1 PROCESS FOR PREPARING 2,6-DIAMINO-4,5,6,7-TETRAHYDRO-BENZOTHIAZOLE Cipla Ltd. (IN) 2005-08-17 EP claimed
WO-2004041797-A1 PROCESS FOR PREPARING 2,6-DIAMINO-4,5,6,7-TETRAHYDRO-BENZOTHIAZOLE CIPLA LTD (IN) 2004-05-21 WO claimed
CN-116178304-B Synthesis method of pramipexole dihydrochloride 中国药科大学 2024-10-25 CN disclosed
CN-116178304-A Synthesis method of pramipexole dihydrochloride 中国药科大学 2023-05-30 CN disclosed
CN-112608286-B Preparation method of high-purity pramipexole 广东红珊瑚药业有限公司 2022-09-30 CN disclosed
CN-112608286-A Preparation method of high-purity pramipexole 广东红珊瑚药业有限公司 2021-04-06 CN disclosed
CN-111362884-A Industrial preparation method of 2, 6-diamino-4, 5,6, 7-tetrahydro-benzothiazole 江苏神龙药业股份有限公司 2020-07-03 CN disclosed
CN-111362884-A Industrial preparation method of 2, 6-diamino-4, 5,6, 7-tetrahydro-benzothiazole 江苏神龙药业股份有限公司 2020-07-03 CN disclosed
EP-1562921-A1 PROCESS FOR PREPARING 2,6-DIAMINO-4,5,6,7-TETRAHYDRO-BENZOTHIAZOLE Cipla Ltd. (IN) 2005-08-17 EP disclosed
WO-2004041797-A1 PROCESS FOR PREPARING 2,6-DIAMINO-4,5,6,7-TETRAHYDRO-BENZOTHIAZOLE CIPLA LTD (IN) 2004-05-21 WO disclosed
US-4886812-A REGULATING DOPAMINE CONCENTRATION; PARKINSON DISEASE, HYPOTENSIVE AGENT, SCHIZOPHRENIA DR. KARL THOMAE GMBH (DE) 1989-12-12 US disclosed
US-4843086-A HYPOTENSIVE AGENTS, SCHIZOPHRENIA, PARKINSON'S DISEASE BOEHRINGER INGELHEIM KG (DE) 1989-06-27 US disclosed
US-4731374-A PARKINSON*S DISEASE DR. KARL THOMAE GMBH (DE) 1988-03-15 US disclosed
EP-0186087-A1 Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs Dr. Karl Thomae GmbH (DE) 1986-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100256-A1 Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole DNPEP, DDO, HNMT SCN4A 2954/4885SCN3A 4555/4885SCN9A 3132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.